Opko Health (OPK)

• Market cap: $1.1B
• 1 day: -1.43%
• 5 days: -1.43%
• 1 month: 0.73%
• 3 months: 3.76%
• 6 months: -23.76%
• Year to date: -4.83%
• 1 year: -15.85%
• 5 years: -56.19%
• 10 years: -86.64%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Employees: 2,997

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

562% more call options, than puts

Call options by funds: $3.77M | Put options by funds: $569K

10.05% less ownership

Funds ownership: 35.98% [Q1] → 25.93% (-10.05%) [Q2]

13% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 64

13% less funds holding

Funds holding: 252 [Q1] → 218 (-34) [Q2]

32% less capital invested

Capital invested by funds: $401M [Q1] → $271M (-$130M) [Q2]

65% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 49